These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 856391)

  • 1. Idiopathic recurrent superficial thrombophlebitis: treatment with fibrinolytic enhancement.
    Jarrett PE; Morland M; Browse NL
    Br Med J; 1977 Apr; 1(6066):933-4. PubMed ID: 856391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis of recurrent venous thrombosis with long-term enhancement of fibrinolysis.
    Bielawiec M; Lukjan H; Myśliwiec M; Dabrowski S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):971-6. PubMed ID: 94894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of phenformin plus stanozolol on fibrinolysis, platelet adhesiveness and blood lipids in patients with recurrent venous thrombosis.
    Bielawiec M; Myśliwiec M; Perzanowski A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):483-8. PubMed ID: 4139068
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and laboratory double-blind investigation on effect of fibrinolytic therapy in patients with cutaneous vasculitis.
    Dodman B; Cunliffe WJ; Roberts BE; Sibbald R
    Br Med J; 1973 Apr; 2(5858):82-4. PubMed ID: 4573315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical investigations on long-term activation of fibrinolysis by anabolic steroids.
    Bielawiec M; Bodzenta A; Lukjan H; Kiersnowska-Rogowska B; Kłoczko J; Myśliwiec M; Dabrowski S; Tymiński W; Czestochowska E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):223-9. PubMed ID: 2427405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).
    Menon IS
    Acta Univ Carol Med Monogr; 1972; 52():19-23. PubMed ID: 4669824
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of combined treatment with phenformin and stanazolol on blood lipids and fibrinolytic activity in patients with hypertriglyceridaemia.
    Ciświcka-Sznajderman M; Berent H; Rymaszewski Z
    Atherosclerosis; 1974; 19(1):153-9. PubMed ID: 4359182
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenformin and ethyloestrenol in recurrent venous thrombosis.
    Nilsson IM; Hedner U; Isacson S
    Acta Med Scand; 1975; 198(1-2):107-13. PubMed ID: 1166815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The 131I-fibrinogen turnover during activation of blood fibrinolysis].
    Grabowski R; Bielawiec M; Kiersnowska B; Lukjan H; Perzanowski A; Mysliwiec M; Korfel B; Rogowski F
    Z Gesamte Inn Med; 1976 Dec; 31(24):1025-7. PubMed ID: 1020408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic enhancement by stanozolol: a double-blind trial.
    Davidson JF; McDonald GA; McNicol GP
    J Clin Pathol; 1972 Jul; 25(7):639. PubMed ID: 4560843
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems.
    Nilsson IM; Isacson S
    J Clin Pathol; 1972 Jul; 25(7):638-9. PubMed ID: 5070268
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of ethyloestrenol on fibrinolysis in the vessel wall.
    Hedner U; Nilsson IM; Isacson S
    Br Med J; 1976 Sep; 2(6038):729-31. PubMed ID: 974570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of the biguanide moroxydine chloride to stimulate plasma fibrinolytic activity.
    Boberg M; Killander A
    Acta Med Scand; 1984; 215(3):221-4. PubMed ID: 6731035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolytic enhancement with stanozolol fails to improve symptoms and signs in patients with post-surgical back pain.
    Cooper RG; Mitchell WS; Illingworth KJ; Jayson MI
    Scand J Rheumatol; 1991; 20(6):414-8. PubMed ID: 1837614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behçet's syndrome and oral fibrinolytic therapy.
    Cunliffe WJ; Roberts BE; Dodman B
    Br Med J; 1973 May; 2(5864):486-7. PubMed ID: 4712497
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative effects of platelet adhesiveness by phenformin combined with ethylestrenol or stanozolol.
    Chakrabarti R
    Acta Univ Carol Med Monogr; 1972; 53():261-2. PubMed ID: 4670736
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of platelet suppressant, anticoagulant and fibrinolytic therapy in patients with recurrent venous thrombosis.
    Steele P; Ellis J; Genton E
    Am J Med; 1978 Mar; 64(3):441-5. PubMed ID: 345802
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Fibrinolysis and deep-vein thrombosis.
    Fearnley GR
    Lancet; 1974 Mar; 1(7855):454-5. PubMed ID: 4131453
    [No Abstract]   [Full Text] [Related]  

  • 19. Mode of action of phenformin plus ethyloestrenol on fibrinolysis.
    Fearnley GR; Chakrabarti R; Evans JF
    Lancet; 1971 Apr; 1(7702):723-5. PubMed ID: 4101428
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Raynaud's phenomenon by fibrinolytic enhancement.
    Jarrett PE; Morland M; Browse NL
    Br Med J; 1978 Aug; 2(6136):523-5. PubMed ID: 698554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.